Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleic acids and ribosomes constitute the essential apparatus for the storage, transmission, and expression of genetic information. Nucleic acids, comprising deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), serve as the templates for life, while ribosomes are complex ribonucleoprotein machines responsible for translating genetic codes into functional proteins (Wilson, D. N., Nature Reviews Microbiology, 2014 [1]). In clinical practice, these entities are major therapeutic targets, particularly for antibiotics that exploit structural differences between prokaryotic and eukaryotic ribosomes to selectively inhibit bacterial protein synthesis (StatPearls, "Physiology, Ribosome", 2023 [2]). Additionally, many antineoplastic agents target DNA through intercalation, alkylation, or by inhibiting topoisomerases, thereby inducing DNA damage and apoptosis in rapidly dividing cancer cells (Pommier, Y., Nature Reviews Cancer, 2006 [3]). While highly effective, drugs targeting these systems often face challenges such as the development of molecular resistance and off-target toxicity, particularly when therapeutic agents cross-react with human mitochondrial machinery (Neidle, S., Nature Reviews Drug Discovery, 2002 [4]).
Inhibition of the 30S or 50S ribosomal subunits to prevent protein synthesis; inhibition of DNA topoisomerases or RNA polymerases to disrupt replication and transcription; direct DNA intercalation or alkylation to induce structural damage.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleic acids and ribosomes.